Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.85M Buy
21,288
+1,812
+9% +$512K 0.02% 540
2026
Q1
$5.18M Buy
19,476
+2,294
+13% +$635K 0.03% 513
2025
Q4
$4.73M Buy
17,182
+3,405
+25% +$955K 0.02% 516
2025
Q3
$3.95M Buy
13,777
+2,438
+22% +$721K 0.03% 497
2025
Q2
$3.75M Buy
11,339
+1,935
+21% +$624K 0.03% 452
2025
Q1
$3.06M Buy
9,404
+1,375
+17% +$414K 0.03% 415
2024
Q4
$2.25M Buy
8,029
+637
+9% +$203K 0.03% 466
2024
Q3
$2.56M Buy
7,392
+3,483
+89% +$1.2M 0.05% 316
2024
Q2
$1.29M Buy
3,909
+3,005
+332% +$1.04M 0.06% 286
2024
Q1
$328K Buy
+904
New +$298K 0.05% 342
2021
Q1
Sell
-1,542
Closed -$321K 159
2020
Q4
$321K Hold
1,542
0.27% 85
2020
Q3
$261K Hold
1,542
0.27% 90
2020
Q2
$289K Sell
1,542
-62
-4% -$11.8K 0.35% 77
2020
Q1
$284K Hold
1,604
0.44% 70
2019
Q4
$328K Buy
+1,604
New +$294K 0.39% 90
2019
Q2
Sell
-1,499
Closed -$241K 155
2019
Q1
$241K Buy
1,499
+260
+21% +$47.5K 0.35% 100
2018
Q4
$235K Buy
+1,239
New +$258K 0.39% 91

Other funds holding CI

&Partners's CI Position: Q2 2026 in Review

&Partners increased its Cigna (CI) stake by 9.3% in Q2 2026, buying an estimated $512K and bringing the position to 21,288 shares worth $5.85M. The position accounts for 0.02% of the portfolio, ranked #540.

&Partners first reported a position in CI in Q4 2018 and has held it in 17 quarters since. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • &Partners held 21,288 shares of Cigna worth $5.85M as of Q2 2026.
  • &Partners bought 1,812 Cigna shares in Q2 2026, an estimated $512K.
  • Cigna made up 0.02% of &Partners's portfolio in Q2 2026, its #540 holding.
  • &Partners first reported a position in Cigna in Q4 2018 and has held it in 17 quarters since.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.